These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22177408)

  • 21. Design, synthesis and structure-activity relationship of simple bis-amides as potent inhibitors of GlyT1.
    Jolidon S; Alberati D; Dowle A; Fischer H; Hainzl D; Narquizian R; Norcross R; Pinard E
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5533-6. PubMed ID: 18805008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel class of adenosine A3 receptor ligands. 2. Structure affinity profile of a series of isoquinoline and quinazoline compounds.
    van Muijlwijk-Koezen JE; Timmerman H; Link R; van der Goot H; Ijzerman AP
    J Med Chem; 1998 Oct; 41(21):3994-4000. PubMed ID: 9767637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of GlyT1 inhibitors with improved pharmacokinetic properties.
    Wolkenberg SE; Zhao Z; Wisnoski DD; Leister WH; O'Brien J; Lemaire W; Williams DL; Jacobson MA; Sur C; Kinney GG; Pettibone DJ; Tiller PR; Smith S; Gibson C; Ma BK; Polsky-Fisher SL; Lindsley CW; Hartman GD
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1492-5. PubMed ID: 19181525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of Novel Aminotetralines and Aminochromanes as Selective and Competitive Glycine Transporter 1 (GlyT1) Inhibitors.
    Amberg W; Lange UEW; Ochse M; Pohlki F; Behl B; Relo AL; Hornberger W; Hoft C; Mezler M; Sydor J; Wang Y; Zhao H; Brewer JT; Dietrich J; Li H; Akritopoulou-Zanze I; Lao Y; Hannick SM; Ku YY; Vasudevan A
    J Med Chem; 2018 Sep; 61(17):7503-7524. PubMed ID: 30080045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 4-(Phenylaminomethylene)isoquinoline-1,3(2H,4H)-diones as potent and selective inhibitors of the cyclin-dependent kinase 4 (CDK4).
    Tsou HR; Otteng M; Tran T; Floyd MB; Reich M; Birnberg G; Kutterer K; Ayral-Kaloustian S; Ravi M; Nilakantan R; Grillo M; McGinnis JP; Rabindran SK
    J Med Chem; 2008 Jun; 51(12):3507-25. PubMed ID: 18494457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel class of adenosine A3 receptor ligands. 1. 3-(2-Pyridinyl)isoquinoline derivatives.
    van Muijlwijk-Koezen JE; Timmerman H; Link R; van der Goot H; IJzerman AP
    J Med Chem; 1998 Oct; 41(21):3987-93. PubMed ID: 9767636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imidazoquinolinone, imidazopyridine, and isoquinolindione derivatives as novel and potent inhibitors of the poly(ADP-ribose) polymerase (PARP): a comparison with standard PARP inhibitors.
    Eltze T; Boer R; Wagner T; Weinbrenner S; McDonald MC; Thiemermann C; Bürkle A; Klein T
    Mol Pharmacol; 2008 Dec; 74(6):1587-98. PubMed ID: 18809672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of 3-hydroxy-4-cyano-isoquinolines as novel, potent, and selective inhibitors of human 11β-hydroxydehydrogenase 1 (11β-HSD1).
    Wu SC; Yoon D; Chin J; van Kirk K; Seethala R; Golla R; He B; Harrity T; Kunselman LK; Morgan NN; Ponticiello RP; Taylor JR; Zebo R; Harper TW; Li W; Wang M; Zhang L; Sleczka BG; Nayeem A; Sheriff S; Camac DM; Morin PE; Everlof JG; Li YX; Ferraro CA; Kieltyka K; Shou W; Vath MB; Zvyaga TA; Gordon DA; Robl JA
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6693-8. PubMed ID: 21983444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and biological evaluation of analogues of 7-chloro-4,5-dihydro-4- oxo-8-(1,2,4-triazol-4-yl)-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylic acid (TQX-173) as novel selective AMPA receptor antagonists.
    Catarzi D; Colotta V; Varano F; Calabri FR; Filacchioni G; Galli A; Costagli C; Carlà V
    J Med Chem; 2004 Jan; 47(1):262-72. PubMed ID: 14695840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, structure-activity relationship and in vitro biological evaluation of N-arylethyl isoquinoline derivatives as Coxsackievirus B3 inhibitors.
    Wang YX; Li YH; Li YH; Gao RM; Wang HQ; Liu YX; Gao LM; Lu QN; Jiang JD; Song DQ
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5787-90. PubMed ID: 21880491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and anticonvulsant evaluation of N-substituted isoquinoline AMPA receptor antagonists.
    Gitto R; De Luca L; Pagano B; Citraro R; De Sarro G; Costa L; Ciranna L; Chimirri A
    Bioorg Med Chem; 2008 Mar; 16(5):2379-84. PubMed ID: 18077172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimisation of a series of potent, selective and orally bioavailable GlyT1 inhibitors.
    Thomson JL; Blackaby WP; Jennings AS; Goodacre SC; Pike A; Thomas S; Brown TA; Smith A; Pillai G; Street LJ; Lewis RT
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2235-9. PubMed ID: 19318248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 1,3-diaminopropan-2-ol sulfonamides as potent and selective inhibitors of the glycine transporter type 1.
    Rahman SS; Coulton S; Herdon HJ; Joiner GF; Jin J; Porter RA
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1741-5. PubMed ID: 17234406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An octahydro-cyclopenta[c]pyrrole series of inhibitors of the type 1 glycine transporter.
    Lowe JA; Deninno SL; Drozda SE; Schmidt CJ; Ward KM; David Tingley F; Sanner M; Tunucci D; Valentine J
    Bioorg Med Chem Lett; 2010 Feb; 20(3):907-11. PubMed ID: 20045321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An aspartate residue in the external vestibule of GLYT2 (glycine transporter 2) controls cation access and transport coupling.
    Pérez-Siles G; Núñez E; Morreale A; Jiménez E; Leo-Macías A; Pita G; Cherubino F; Sangaletti R; Bossi E; Ortíz AR; Aragón C; López-Corcuera B
    Biochem J; 2012 Mar; 442(2):323-34. PubMed ID: 22132725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and biological evaluation of 1-benzyl-5-(3-biphenyl-2-yl-propyl)-1H-imidazole as novel farnesyltransferase inhibitor.
    Lin NH; Wang L; Wang X; Wang GT; Cohen J; Gu WZ; Zhang H; Rosenberg SH; Sham HL
    Bioorg Med Chem Lett; 2004 Oct; 14(20):5057-62. PubMed ID: 15380198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential effect of the benzophenanthridine alkaloids sanguinarine and chelerythrine on glycine transporters.
    Jursky F; Baliova M
    Neurochem Int; 2011 May; 58(6):641-7. PubMed ID: 21315125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and characterization of [¹²⁵I]2-iodo N-[(S)-{(S)-1-methylpiperidin-2-yl}(phenyl)methyl]3-trifluoromethyl-benzamide as novel imaging probe for glycine transporter 1.
    Fuchigami T; Haratake M; Magata Y; Haradahira T; Nakayama M
    Bioorg Med Chem; 2011 Nov; 19(21):6245-53. PubMed ID: 21975065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery, synthesis and biological evaluation of isoquinolones as novel and highly selective JNK inhibitors (1).
    Asano Y; Kitamura S; Ohra T; Aso K; Igata H; Tamura T; Kawamoto T; Tanaka T; Sogabe S; Matsumoto S; Yamaguchi M; Kimura H; Itoh F
    Bioorg Med Chem; 2008 Apr; 16(8):4715-32. PubMed ID: 18313304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis and biological activity of selective and orally available TF/FVIIa complex inhibitors containing non-amidine P1 ligands.
    Miura M; Seki N; Koike T; Ishihara T; Niimi T; Hirayama F; Shigenaga T; Sakai-Moritani Y; Tagawa A; Kawasaki T; Sakamoto S; Okada M; Ohta M; Tsukamoto S
    Bioorg Med Chem; 2007 Jan; 15(1):160-73. PubMed ID: 17064913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.